{
  "abstract": "Bronchiectasis is a chronic respiratory disorder characterised by airway dilation, persistent mucus production and recurrent respiratory exacerbations. Although it remains under-recognised, particularly among children and adolescents, growing epidemiological evidence underscored its rising incidence and prevalence, as well as its significant burden on healthcare systems.1 Despite progress in imaging, microbiology and airway clearance methods, management still tends to be based on empirical and standardised approaches, which do not capture the marked variability seen in clinical presentation, disease severity, frequency of exacerbations and how patients respond to treatment.2 In adult bronchiectasis, the identification of clinical phenotypes substantially improved patient stratification, prognostication and therapeutic individualisation.3 4 In contrast, paediatric bronchiectasis has remained largely without validated clinical phenotypes capable of guiding treatment decisions or informing clinical trial design.",
  "authors": [
    {
      "affiliations": [
        "SC Pneumologia, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy",
        "School of Medicine and Surgery, University of Milano Bicocca, Milano, Italy"
      ],
      "name": "Giovanni Franco"
    },
    {
      "affiliations": [
        "SC Pneumologia, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy",
        "School of Medicine and Surgery, University of Milano Bicocca, Milano, Italy"
      ],
      "name": "Fabrizio Luppi"
    },
    {
      "affiliations": [
        "SC Pneumologia, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy",
        "School of Medicine and Surgery, University of Milano Bicocca, Milano, Italy"
      ],
      "name": "Paola Faverio"
    }
  ],
  "title": "Paediatric bronchiectasis: clinical phenotypes and future directions",
  "uid": "ce897217-34ec-562f-a50e-3f79e2122b2f"
}